Harvard Bioscience Inc (FRA:HBI0)
€ 4.08 (0%) Market Cap: 29.14 Mil Enterprise Value: 61.40 Mil PE Ratio: 0 PB Ratio: 4.59 GF Score: 53/100

Harvard Bioscience Inc Annual Shareholders Meeting Transcript

Jun 02, 2026 / 02:00PM GMT
Release Date Price: €4.08
Operator

Good morning.

John Duke
Harvard Bioscience Inc - President, Chief Executive Officer, Director

Good morning, ladies and gentlemen.

Operator

Please go ahead, sir. Thank you.

John Duke
Harvard Bioscience Inc - President, Chief Executive Officer, Director

Sorry. Good morning, ladies and gentlemen. I'm John Duke, President and Chief Executive Officer of Harvard Bioscience. It is my pleasure to preside over our company's 2026 annual meeting. I will act as Chairman of this meeting. We are pleased to be once again hosting our meeting using a virtual-only format, which allows our shareholders to participate in the meeting through a convenient online portal. This meeting is officially called to order.

I would like to start by acknowledging the other directors of the company who are present today: Katherine Eade, Robert Gagnon, Seth Benson, Stephen DeNelsky, William Snyder. I would also like to note that Anden Utzinger from our independent auditor, Grant Thornton, and Megan Gates

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot